Cargando…
Formulation and in vitro evaluation of self-nanoemulsifying liquisolid tablets of furosemide
Self-nanoemulsifying drug delivery systems (SNEDDS) were used to enhance the dissolution rate of furosemide as a model for class IV drugs and the system was solidified into liquisolid tablets. SNEDDS of furosemide contained 10% Castor oil, 60% Cremophor EL, and 30% PEG 400. The mean droplets size wa...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809212/ https://www.ncbi.nlm.nih.gov/pubmed/33446749 http://dx.doi.org/10.1038/s41598-020-79940-5 |
_version_ | 1783637072539549696 |
---|---|
author | Dalal, Lena Allaf, Abdul Wahab El-Zein, Hind |
author_facet | Dalal, Lena Allaf, Abdul Wahab El-Zein, Hind |
author_sort | Dalal, Lena |
collection | PubMed |
description | Self-nanoemulsifying drug delivery systems (SNEDDS) were used to enhance the dissolution rate of furosemide as a model for class IV drugs and the system was solidified into liquisolid tablets. SNEDDS of furosemide contained 10% Castor oil, 60% Cremophor EL, and 30% PEG 400. The mean droplets size was 17.9 ± 4.5 nm. The theoretical model was used to calculate the amounts of the carrier (Avicel PH101) and coating materials (Aerosil 200) to prepare liquisolid powder. Carrier/coating materials ratio of 5/1 was used and Ludipress was added to the solid system, thus tablets with hardness of 45 ± 2 N were obtained. Liquisolid tablets showed 2-folds increase in drug release as compared to the generic tablets after 60 min in HCl 0.1 N using USP apparatus-II. Furosemide loaded SNEDDS tablets have great prospects for further in vivo studies, and the theoretical model is useful for calculating the adequate amounts of adsorbents required to solidify these systems. |
format | Online Article Text |
id | pubmed-7809212 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-78092122021-01-15 Formulation and in vitro evaluation of self-nanoemulsifying liquisolid tablets of furosemide Dalal, Lena Allaf, Abdul Wahab El-Zein, Hind Sci Rep Article Self-nanoemulsifying drug delivery systems (SNEDDS) were used to enhance the dissolution rate of furosemide as a model for class IV drugs and the system was solidified into liquisolid tablets. SNEDDS of furosemide contained 10% Castor oil, 60% Cremophor EL, and 30% PEG 400. The mean droplets size was 17.9 ± 4.5 nm. The theoretical model was used to calculate the amounts of the carrier (Avicel PH101) and coating materials (Aerosil 200) to prepare liquisolid powder. Carrier/coating materials ratio of 5/1 was used and Ludipress was added to the solid system, thus tablets with hardness of 45 ± 2 N were obtained. Liquisolid tablets showed 2-folds increase in drug release as compared to the generic tablets after 60 min in HCl 0.1 N using USP apparatus-II. Furosemide loaded SNEDDS tablets have great prospects for further in vivo studies, and the theoretical model is useful for calculating the adequate amounts of adsorbents required to solidify these systems. Nature Publishing Group UK 2021-01-14 /pmc/articles/PMC7809212/ /pubmed/33446749 http://dx.doi.org/10.1038/s41598-020-79940-5 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Dalal, Lena Allaf, Abdul Wahab El-Zein, Hind Formulation and in vitro evaluation of self-nanoemulsifying liquisolid tablets of furosemide |
title | Formulation and in vitro evaluation of self-nanoemulsifying liquisolid tablets of furosemide |
title_full | Formulation and in vitro evaluation of self-nanoemulsifying liquisolid tablets of furosemide |
title_fullStr | Formulation and in vitro evaluation of self-nanoemulsifying liquisolid tablets of furosemide |
title_full_unstemmed | Formulation and in vitro evaluation of self-nanoemulsifying liquisolid tablets of furosemide |
title_short | Formulation and in vitro evaluation of self-nanoemulsifying liquisolid tablets of furosemide |
title_sort | formulation and in vitro evaluation of self-nanoemulsifying liquisolid tablets of furosemide |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809212/ https://www.ncbi.nlm.nih.gov/pubmed/33446749 http://dx.doi.org/10.1038/s41598-020-79940-5 |
work_keys_str_mv | AT dalallena formulationandinvitroevaluationofselfnanoemulsifyingliquisolidtabletsoffurosemide AT allafabdulwahab formulationandinvitroevaluationofselfnanoemulsifyingliquisolidtabletsoffurosemide AT elzeinhind formulationandinvitroevaluationofselfnanoemulsifyingliquisolidtabletsoffurosemide |